Limits...
The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot study.

Poelaert F, Van Praet C, Beerens AS, De Meerleer G, Fonteyne V, Ost P, Lumen N - Biomed Res Int (2015)

Bottom Line: Preliminary results of this research show already a promising role of differential AR expression in predicting clinical relapse after PCa treatment with primary EBRT.Further research is needed to validate these findings.Hopefully this can lead to a better understanding of PCa evolution and eventually lead to better therapy strategies.

View Article: PubMed Central - PubMed

Affiliation: Department of Urology, Ghent University Hospital, De Pintelaan 185, 9000 Gent, Belgium.

ABSTRACT
The androgen receptor (AR) and its signaling pathway play an important role in the development and progression of prostate cancer (PCa). In the setting of primary treatment of PCa with radiotherapy (RT), where the AR can be expected to be of more importance, studies evaluating the AR expression are lacking. The goal of this research is to evaluate AR protein expression in hormone-naive PCa patients treated by RT and investigate its possible prognostic role. Primary biopsy samples of 18 patients treated with primary RT were analyzed including the corresponding clinical information. AR protein expression of the tumor epithelium (with highest Gleason pattern) and the surrounding stroma was quantified using the Quick score for steroid receptors. The differential expression between epithelium and stroma, respectively, between tumor and normal tissue (ΔTumor - ΔBenign >2 versus ≤ 2), was predictive for clinical progression-free survival in the biopsy samples (P = 0.014). Preliminary results of this research show already a promising role of differential AR expression in predicting clinical relapse after PCa treatment with primary EBRT. Further research is needed to validate these findings. Hopefully this can lead to a better understanding of PCa evolution and eventually lead to better therapy strategies.

Show MeSH

Related in: MedlinePlus

Clinical progression-free survival subdivided by ΔTumor − ΔBenign >2 versus ≤2 for all biopsy samples (1 missing value of normal stroma).
© Copyright Policy - open-access
Related In: Results  -  Collection


getmorefigures.php?uid=PMC4352440&req=5

fig4: Clinical progression-free survival subdivided by ΔTumor − ΔBenign >2 versus ≤2 for all biopsy samples (1 missing value of normal stroma).

Mentions: Within the biopsy samples of the primary EBRT group, only the differential expression remained significant for clinical progression-free survival (log-rank: P = 0.014, Figure 4).


The role of androgen receptor expression in the curative treatment of prostate cancer with radiotherapy: a pilot study.

Poelaert F, Van Praet C, Beerens AS, De Meerleer G, Fonteyne V, Ost P, Lumen N - Biomed Res Int (2015)

Clinical progression-free survival subdivided by ΔTumor − ΔBenign >2 versus ≤2 for all biopsy samples (1 missing value of normal stroma).
© Copyright Policy - open-access
Related In: Results  -  Collection

Show All Figures
getmorefigures.php?uid=PMC4352440&req=5

fig4: Clinical progression-free survival subdivided by ΔTumor − ΔBenign >2 versus ≤2 for all biopsy samples (1 missing value of normal stroma).
Mentions: Within the biopsy samples of the primary EBRT group, only the differential expression remained significant for clinical progression-free survival (log-rank: P = 0.014, Figure 4).

Bottom Line: Preliminary results of this research show already a promising role of differential AR expression in predicting clinical relapse after PCa treatment with primary EBRT.Further research is needed to validate these findings.Hopefully this can lead to a better understanding of PCa evolution and eventually lead to better therapy strategies.

View Article: PubMed Central - PubMed

Affiliation: Department of Urology, Ghent University Hospital, De Pintelaan 185, 9000 Gent, Belgium.

ABSTRACT
The androgen receptor (AR) and its signaling pathway play an important role in the development and progression of prostate cancer (PCa). In the setting of primary treatment of PCa with radiotherapy (RT), where the AR can be expected to be of more importance, studies evaluating the AR expression are lacking. The goal of this research is to evaluate AR protein expression in hormone-naive PCa patients treated by RT and investigate its possible prognostic role. Primary biopsy samples of 18 patients treated with primary RT were analyzed including the corresponding clinical information. AR protein expression of the tumor epithelium (with highest Gleason pattern) and the surrounding stroma was quantified using the Quick score for steroid receptors. The differential expression between epithelium and stroma, respectively, between tumor and normal tissue (ΔTumor - ΔBenign >2 versus ≤ 2), was predictive for clinical progression-free survival in the biopsy samples (P = 0.014). Preliminary results of this research show already a promising role of differential AR expression in predicting clinical relapse after PCa treatment with primary EBRT. Further research is needed to validate these findings. Hopefully this can lead to a better understanding of PCa evolution and eventually lead to better therapy strategies.

Show MeSH
Related in: MedlinePlus